"We continue to grow and strengthen the Group's profitability. With an EBITA margin of 15.7%, we are exceeding our long-term financial target - a testament to the strength of our decentralized model a ...

Q4 2024 Earnings Call Transcript April 30, 2025 PureTech Health plc beats earnings expectations. Reported EPS is $3.98, expectations were $-2.83. Operator: Greetings and welcome to the PureTech Health ...

In order to acquire Hillrom in late 2021, Baxter increased leverage substantially. On a net leverage basis, Baxter expanded its pro forma leverage from only 1 times as of June 2021 to the low 4s after ...

The DSV Group achieved higher earnings in Q1 2025 compared to the same period last year in volatile and uncertain markets. The earnings growth was driven by improved gross profit, especially in ...

An update on the integration will be communicated in connection with the release of DSV's H1 interim financial report, which is postponed from 24 July 2025 to 31 July 2025. The current geopolitical ...

or €5.01/share Proposed dividend for the 2025 financial year: €4.00/share (gross), representing a pay-out ratio of 80% of consolidated EPRA Earnings ...

The Company also confirms that it has filed its interim financial statements for the ... We provide a platform for our authors to report on investments fairly, accurately, and from the investor ...

Of these, 26 homes were delivered in Tallinn, and 16 in Riga. During the reporting quarter, construction and sales continued on the first phase of the main building of the former Baltic Cotton ...

the stock’s decline suggests that investors may have concerns about the small patient sample size and the generalizability of the results. The company is on track to present updated interim data ...